324 related articles for article (PubMed ID: 33236884)
1. Residence Time-Extended Nanoparticles by Magnetic Field Improve the Eradication Efficiency of
Yang SJ; Huang CH; Yang JC; Wang CH; Shieh MJ
ACS Appl Mater Interfaces; 2020 Dec; 12(49):54316-54327. PubMed ID: 33236884
[No Abstract] [Full Text] [Related]
2. Anti-Helicobacterpylori effectiveness and targeted delivery performance of amoxicillin-UCCs-2/TPP nanoparticles based on ureido-modified chitosan derivative.
Jing ZW; Luo M; Jia YY; Li C; Zhou SY; Mei QB; Zhang BL
Int J Biol Macromol; 2018 Aug; 115():367-374. PubMed ID: 29660462
[TBL] [Abstract][Full Text] [Related]
3. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
Thombre NA; Gide PS
Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
[TBL] [Abstract][Full Text] [Related]
4. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
Rajinikanth PS; Balasubramaniam J; Mishra B
Int J Pharm; 2007 Apr; 335(1-2):114-122. PubMed ID: 17141986
[TBL] [Abstract][Full Text] [Related]
6. The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.
Gonçalves IC; Henriques PC; Seabra CL; Martins MC
Expert Rev Anti Infect Ther; 2014 Aug; 12(8):981-92. PubMed ID: 24981812
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
[TBL] [Abstract][Full Text] [Related]
8. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
Umamaheshwari RB; Ramteke S; Jain NK
AAPS PharmSciTech; 2004 Apr; 5(2):e32. PubMed ID: 15760090
[TBL] [Abstract][Full Text] [Related]
9. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
Patel JK; Chavda JR
J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
[TBL] [Abstract][Full Text] [Related]
11. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial evaluating amoxicillin and clarithromycin hydrogels (Chitosan-polyacrylic acid polyionic complex) for H. pylori eradication.
Gisbert JP; Torrado G; Torrado S; Olivares D; Pajares JM
J Clin Gastroenterol; 2006 Aug; 40(7):618-22. PubMed ID: 16917404
[TBL] [Abstract][Full Text] [Related]
13. Floating mucoadhesive alginate beads of amoxicillin trihydrate: A facile approach for H. pylori eradication.
Dey SK; De PK; De A; Ojha S; De R; Mukhopadhyay AK; Samanta A
Int J Biol Macromol; 2016 Aug; 89():622-31. PubMed ID: 27177460
[TBL] [Abstract][Full Text] [Related]
14. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.
Kato M; Ota H; Okuda M; Kikuchi S; Satoh K; Shimoyama T; Suzuki H; Handa O; Furuta T; Mabe K; Murakami K; Sugiyama T; Uemura N; Takahashi S
Helicobacter; 2019 Aug; 24(4):e12597. PubMed ID: 31111585
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro studies of cross-linked hydrogel nanoparticles containing amoxicillin.
Moogooee M; Ramezanzadeh H; Jasoori S; Omidi Y; Davaran S
J Pharm Sci; 2011 Mar; 100(3):1057-66. PubMed ID: 21280053
[TBL] [Abstract][Full Text] [Related]
17. Smart drug delivery against Helicobacter pylori: pectin-coated, mucoadhesive liposomes with antiadhesive activity and antibiotic cargo.
Gottesmann M; Goycoolea FM; Steinbacher T; Menogni T; Hensel A
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5943-5957. PubMed ID: 32399588
[TBL] [Abstract][Full Text] [Related]
18. [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Kim JY; Kim N; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Nam RH; Kim JM; Lee JH; Jung HC; Song IS
Korean J Gastroenterol; 2011 Dec; 58(2):74-81. PubMed ID: 21873821
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
20. High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.
Mahmoudi L; Farshad S; Seddigh M; Mahmoudi P; Ejtehadi F; Niknam R
Medicine (Baltimore); 2016 Oct; 95(42):e4410. PubMed ID: 27759625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
